PRESS RELEASE
News
-
-
PRESS RELEASE
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
NanoViricides reports successful completion of Phase I Clinical Trial of NV-387, progresses towards Phase II discussion with physicians and experts for dosing protocol determination -
-
REGULATED PRESS RELEASE
Annual Ordinary Shareholders’ Meeting of May 23, 2024, availability of preliminary documents for the Annual General Meeting
Safran announces availability of preliminary documents for the Annual Ordinary Shareholders' Meeting to be held on May 23, 2024 at Safran Campus, Massy, France -
-
-
PRESS RELEASE
MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
MindBio Therapeutics Corp. has received regulatory approval for clinical trials using MB22001 to address PMS and PMDD in menstruating individuals. The trials aim to assess the drug's mood-related effects during different menstrual phases -
-
PRESS RELEASE
Reggora Partners With Loan Originator Networks to Automate Appraisal Order Compliance From Wholesale Brokers and Non Delegated Correspondents
Reggora partners with Loan Originator Networks to ensure appraisal orders from third-party brokers comply with updated appraiser independence requirements, improving efficiency and borrower experience -
